On July 16th we noted pharma and biotechs were working on noteworthy, long-term technical break-outs. Regarding those groups, we said the following in that prior post: “The set-up in bio-tech is the most compelling given that the DJ Bio-tech index has already … Continue reading Biotechs Should Continue to Out-Perform Materially